A recent study demonstrated that CTHRC1 could promote ERK and JNK phosphorylation by activating PCP signaling pathways in human umbilical vein endothelial cells (HUVECs) and promote tumor angiogenesis [101]. Here, MAPK1 is linked to neoplasm.